dbacp02659
General Description
Peptide name : Dermaseptin-B3
Source/Organism : Giant leaf frog
Linear/Cyclic : Not found
Chirality : Not found
Sequence Information
Sequence : ALWKnMLKGIGKLAGQAALGAVKTLVGAE
Peptide length: 29
C-terminal modification: Not found
N-terminal modification : Free
Non-natural peptide information: None
Activity Information
Assay type : In vitro proliferation assay, Soft agar assay
Assay time : 48h
Activity : EC50 : 2 μM
Cell line : PC-3
Cancer type : Human epithelial prostate adenocarcinoma
Other activity : Not found
Physicochemical Properties
Amino acid composition bar chart :
Molecular mass : 2909.4916 Dalton
Aliphatic index : 1.213
Instability index : -6.5931
Hydrophobicity (GRAVY) : 0.5138
Isoelectric point : 10.001
Charge (pH 7) : 2.7999
Aromaticity : 0.034
Molar extinction coefficient (cysteine, cystine): (5500, 5500)
Hydrophobic/hydrophilic ratio : 3
hydrophobic moment : -0.732
Missing amino acid : C,R,H,P,F,S,D,Y,N
Most occurring amino acid : A
Most occurring amino acid frequency : 6
Least occurring amino acid : W
Least occurring amino acid frequency : 1
Structural Information
3D structure :
Secondary structure fraction (Helix, Turn, Sheet): (0.5, 0.2, 0.3)
SMILES Notation: CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(C)C)[C@@H](C)O)C(C)C
Secondary Structure :
| Method | Prediction |
|---|---|
| GOR | HHHHHHHHHHHHHHHHHHHHHHEEEEHHH |
| Chou-Fasman (CF) | HHHHHHEEEEHHHHHHHHCCEEEEECCCC |
| Neural Network (NN) | HHHHHHHHCCCCHHHHHHHHHHHHHHCCC |
| Joint/Consensus | HHHHHHHHCCHHHHHHHHHHHHEEECCCC |
Molecular Descriptors and ADMET Properties
Molecular Descriptors: Click here to download
ADMET Properties: Click here to download
Cross Referencing databases
CancerPPD : Not available
ApIAPDB : Not available
CancerPPD2 ID : Not available
Reference
1 : van Zoggel H, et al. Antitumor and angiostatic peptides from frog skin secretions. Amino Acids. 2012; 42:385-95. doi: 10.1007/s00726-010-0815-9
Literature
Paper title : Antitumor and angiostatic peptides from frog skin secretions.
Doi : https://doi.org/10.1007/s00726-010-0815-9
Abstract : The discovery of new molecules with potential antitumor activity continues to be of great importance in cancer research. In this respect, natural antimicrobial peptides isolated from various animal species including humans and amphibians have been found to be of particular interest. Here, we report the presence of two anti-proliferative peptides active against cancer cells in the skin secretions of the South American tree frog, Phyllomedusa bicolor. The crude skin exudate was fractioned by size exclusion gel followed by reverse-phase HPLC chromatography. After these two purification steps, we identified two fractions that exhibited anti-proliferative activity. Sequence analysis indicated that this activity was due to two antimicrobial α-helical cationic peptides of the dermaseptin family (dermaseptins B2 and B3). This result was confirmed using synthetic dermaseptins. When tested in vitro, synthetic B2 and B3 dermaseptins inhibited the proliferation of the human prostatic adenocarcinoma PC-3 cell line by more than 90%, with an EC(50) of around 2-3 μM. No effect was observed on the growth of the NIH-3T3 non-tumor mouse cell line with Drs B2, whereas a slight inhibiting effect was observed with Drs B3 at high dose. In addition, the two fractions obtained after size exclusion chromatography also inhibited PC-3 cell colony formation in soft agar. Interestingly, inhibition of the proliferation and differentiation of activated adult bovine aortic endothelial cells was observed in cells treated with these two fractions. Dermaseptins B2 and B3 could, therefore, represent interesting new pharmacological molecules with antitumor and angiostatic properties for the development of a new class of anticancer drugs.